EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Recent Advances in the Development of Sulfamoyl-Based Hepatitis B Virus Nucleocapsid Assembly Modulators

Sandesha Nayak iD, Jayaraj Gowda iD, Syed Azeem Abbas, Hyejin Kim iD, Soo Bong Han

Viruses · 2023

DOI: 10.3390/v15122367 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2023. Verfasst von Sandesha Nayak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea. Hauptthemen laut MEDLINE: Hepatitis B, Chronic, Hepatitis B. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 146 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Research Institute of Chemical Technology, KRICT.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis B virus (HBV) is the primary contributor to severe liver ailments, encompassing conditions such as cirrhosis and hepatocellular carcinoma. Globally, 257 million people are affected by HBV annually and 887,000 deaths are attributed to it, representing a substantial health burden. Regrettably, none of the existing therapies for chronic hepatitis B (CHB) have achieved satisfactory clinical cure rates. This issue stems from the existence of covalently closed circular DNA (cccDNA), which is difficult to eliminate from the nucleus of infected hepatocytes. HBV genetic material is composed of partially double-stranded DNA that forms complexes with viral polymerase inside an icosahedral capsid composed of a dimeric core protein. The HBV core protein, consisting of 183 to 185 amino acids, plays integral roles in multiple essential functions within the HBV replication process. In this review, we describe the effects of sulfamoyl-based carboxamide capsid assembly modulators (CAMs) on capsid assembly, which can suppress HBV replication and disrupt the production of new cccDNA. We present research on classical, first-generation sulfamoyl benzocarboxamide CAMs, elucidating their structural composition and antiviral efficacy. Additionally, we explore newly identified sulfamoyl-based CAMs, including sulfamoyl bicyclic carboxamides, sulfamoyl aromatic heterocyclic carboxamides, sulfamoyl aliphatic heterocyclic carboxamides, cyclic sulfonamides, and non-carboxamide sulfomoyl-based CAMs. We believe that certain molecules derived from sulfamoyl groups have the potential to be developed into essential components of a well-suited combination therapy, ultimately yielding superior clinical efficacy outcomes in the future.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B, ChronicHepatitis BHumansHepatitis B virusAntiviral AgentsNucleocapsidCapsidCapsid ProteinsDNA, CircularVirus ReplicationDNA, Viral

Stichwörter der Autor:innen

CAMsHBV core proteincccDNAhepatitis B virus

Substanzen

Antiviral AgentsCapsid ProteinsDNA, CircularDNA, Viral

Autor:innen und Institutionen

  • Therapeutics and Biotechnology Division, Korea Research Institute of Chemical Technology, Daejeon 34114, Republic of Korea.
  • Department of Medicinal Chemistry and Pharmacology, University of Science & Technology, Daejeon 34113, Republic of Korea.

ORCID-Profile: Sandesha Nayak, Jayaraj Gowda, Hyejin Kim

Förderung

  • Korea Research Institute of Chemical Technology
  • KRICT

Zitieren

APA

Nayak, S., Gowda, J., Abbas, S. A., Kim, H., & Han, S. B. (2023). Recent Advances in the Development of Sulfamoyl-Based Hepatitis B Virus Nucleocapsid Assembly Modulators. Viruses. https://doi.org/10.3390/v15122367

Vancouver

Nayak S, Gowda J, Abbas SA, Kim H, Han SB. Recent Advances in the Development of Sulfamoyl-Based Hepatitis B Virus Nucleocapsid Assembly Modulators. Viruses. 2023. doi:10.3390/v15122367

BibTeX
@article{Nayak2023,
  author = {Nayak, Sandesha and Gowda, Jayaraj and Abbas, Syed Azeem and Kim, Hyejin and Han, Soo Bong},
  title = {Recent Advances in the Development of Sulfamoyl-Based Hepatitis B Virus Nucleocapsid Assembly Modulators},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15122367}
}
Kostenlos starten →